04/30/2024
7:52 AM | C4 Therapeutics (Filer)
| Form ARS | |
04/29/2024
7:03 AM | C4 Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
7:04 AM | C4 Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024
3:16 PM | C4 Therapeutics (Issuer)
Mossler Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:52 AM | C4 Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
03/08/2024
6:28 PM | Boyle Scott N (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:19 PM | C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/08/2024
6:21 PM | Adams Kendra (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:24 PM | C4 Therapeutics (Issuer)
Schick Kelly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:26 PM | C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
12:11 PM | C4 Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
03/04/2024
6:05 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
8:01 AM | C4 Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024
6:15 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:20 AM | C4 Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
5:18 PM | C4 Therapeutics (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:21 AM | C4 Therapeutics (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
02/14/2024
6:35 AM | C4 Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/09/2024
12:04 PM | C4 Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/05/2024
9:24 AM | C4 Therapeutics (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G | |
02/02/2024
8:34 AM | C4 Therapeutics (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
01/12/2024
3:01 PM | Betta Investment Ltd. (0001990727) (Filed by)
C4 Therapeutics (Subject)
| Form SC 13G | |
01/11/2024
6:05 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:15 PM | C4 Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
01/03/2024
3:12 PM | C4 Therapeutics (Issuer)
Dubin Glenn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
3:30 PM | C4 Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
12/22/2023
3:05 PM | C4 Therapeutics (Subject)
COMMODORE CAPITAL LP (Filed by)
| Form SC 13G | |
12/12/2023
3:28 PM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
6:15 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
3:21 PM | C4 Therapeutics (Issuer)
Hughes Owen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:18 PM | C4 Therapeutics (Issuer)
Hughes Owen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2023
6:05 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
6:31 AM | C4 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023
6:18 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
3:26 PM | C4 Therapeutics (Issuer)
GROGAN DONNA ROY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
3:27 PM | C4 Therapeutics (Issuer)
Dubin Glenn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
3:28 PM | Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
6:20 PM | Adams Kendra (Reporting)
C4 Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/19/2023
6:20 PM | C4 Therapeutics (Issuer)
Mossler Mark (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/19/2023
6:21 PM | Adams Kendra (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
6:22 PM | C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Urgent dollar warning (Ad) Your 2024 Election Money Blueprint
Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today. Find out for free here. |
09/19/2023
6:23 PM | Boyle Scott N (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
6:23 PM | C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
6:23 PM | C4 Therapeutics (Issuer)
Schick Kelly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
6:24 PM | C4 Therapeutics (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
6:16 AM | C4 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
6:09 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2023
3:05 PM | C4 Therapeutics (Issuer)
REYNO LEONARD (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/12/2023
3:06 PM | C4 Therapeutics (Issuer)
REYNO LEONARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:35 PM | BlackRock Inc. (Filed by)
C4 Therapeutics (Subject)
| Form SC 13G/A | |
06/20/2023
6:11 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
3:22 PM | C4 Therapeutics (Issuer)
Salter Malcolm (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:22 PM | C4 Therapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:23 PM | C4 Therapeutics (Issuer)
GROGAN DONNA ROY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:23 PM | C4 Therapeutics (Issuer)
Dubin Glenn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:24 PM | C4 Therapeutics (Issuer)
DOWNEY BRUCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:24 PM | Bessen Laura (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:25 PM | Anderson Kenneth Carl (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
6:30 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
6:46 AM | C4 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
6:34 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2023
11:15 PM | C4 Therapeutics (Filer)
| Form EFFECT | |
